Nc. Karyotakis et Ej. Anaissie, EFFICACY OF CONTINUOUS FLUCYTOSINE INFUSION AGAINST CANDIDA-LUSITANIAE IN EXPERIMENTAL HEMATOGENOUS MURINE CANDIDIASIS, Antimicrobial agents and chemotherapy, 40(12), 1996, pp. 2907-2908
Candida lusitaniae may cause life-threatening infections in the immuno
compromised host and may be resistant to amphotericin B. Flucytosine (
5-FC) is very active against C. lusitaniae isolates in vitro, while th
e in vivo response of murine infection to 5-FC is not as good. To eval
uate the hypothesis that this discrepancy may be primarily due to the
short half-life of 5-FC in mice, we compared the same total dosage of
75 mg of 5-FC per kg of body weight per day given by bolus injections
or infused continuously via a subcutaneously implanted pump in immunos
uppressed CF1 mice infected with C. lusitaniae. The fungal titers in t
he kidneys of mice treated with the continuous 5-FC infusion were sign
ificantly lower (P less than or equal to 0.05) than those in the kidne
ys of mice that received bolus injections once or thrice daily. The an
tifungal activity of 5-FC against murine candidiasis is best evaluated
when the drug is administered by continuous infusion.